Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Regeneron Pharmaceuticals, Inc. (REGN) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Regeneron Pharmaceuticals, Inc. (REGN) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for March 24th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 24th:
The Clorox Company (CLX - Free Report) : This manufacturer of consumer and professional products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days.
The Clorox Company Price and Consensus
The Clorox Company price-consensus-chart | The Clorox Company Quote
Clorox’s shares gained 3.3% over the last one month above the S&P 500’s decrease of 29.4%. The company possesses a Momentum Score of B.
The Clorox Company Price
The Clorox Company price | The Clorox Company Quote
Regeneron Pharmaceuticals, Inc. (REGN - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.3% over the last 60 days.
Regeneron Pharmaceuticals, Inc. Price and Consensus
Regeneron Pharmaceuticals, Inc. price-consensus-chart | Regeneron Pharmaceuticals, Inc. Quote
Regeneron Pharmaceuticals’ shares gained 13% over the last one month. The company possesses a Momentum Score of B.
Regeneron Pharmaceuticals, Inc. Price
Regeneron Pharmaceuticals, Inc. price | Regeneron Pharmaceuticals, Inc. Quote
DHT Holdings, Inc. (DHT - Free Report) : This owner and operator of crude oil tankers has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.1% over the last 60 days.
DHT Holdings, Inc. Price and Consensus
DHT Holdings, Inc. price-consensus-chart | DHT Holdings, Inc. Quote
DHT Holdings’ shares gained 6.7% over the last one month. The company possesses a Momentum Score of A.
DHT Holdings, Inc. Price
DHT Holdings, Inc. price | DHT Holdings, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>